Expressing support for the designation of the week of June 4 through June 10, 2023, as "National Trailer Safety Week" in the United States, and supporting the goals and ideals of National Trailer Safety Week to educate American motorists about the importance of proper towing techniques and maintenance.
- Last Action
- 6/7/2023
Actions
- 2023-05-30Received in the Senate and Read twice and referred to the Committee on the Judiciary.
- 2023-05-25Motion to reconsider laid on the table Agreed to without objection.
- 2023-05-25On passage Passed by the Yeas and Nays: 289 - 133 (Roll no. 237).
- 2023-05-25Passed/agreed to in House: On passage Passed by the Yeas and Nays: 289 - 133 (Roll no. 237).
- 2023-05-25The House adopted the amendment in the nature of a substitute as agreed to by the Committee of the Whole House on the state of the Union.
- 2023-05-25The previous question was ordered pursuant to the rule.
- 2023-05-25The House rose from the Committee of the Whole House on the state of the Union to report H.R. 467.
- 2023-05-25The House resolved into Committee of the Whole House on the state of the Union for further consideration.
- 2023-05-25Considered as unfinished business. (consideration: CR H2605-2607)
- 2023-05-25Committee of the Whole House on the state of the Union rises leaving H.R. 467 as unfinished business.
- 2023-05-25On motion that the committee rise Agreed to by voice vote.
- 2023-05-25Mr. Bucshon moved that the committee rise.
- 2023-05-25POSTPONED PROCEEDINGS - At the conclusion of debate on the Pettersen amendment No. 3, the Chair put the question on adoption of the amendment and by voice vote, announced that the noes had prevailed. Mr. Pallone demanded a recorded vote and the Chair postponed further proceedings until a time to be announced.
- 2023-05-25DEBATE - Pursuant to the provisions of H. Res. 429, the Committee of the Whole proceeded with 10 minutes of debate on the Pettersen amendment No. 3.
- 2023-05-25DEBATE - Pursuant to the provisions of H. Res. 429, the Committee of the Whole proceeded with 10 minutes of debate on the Mills amendment No. 2.
Showing 15 of 20 actions. Full history on Congress.gov.
CRS Summary
As of 2023-05-25 (53)
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act
This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.
(The temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances into schedule I of the Controlled Substances Act expires on December 31, 2024.)
Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).
Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration.
The bill also makes several other changes to registration requirements for conducting research with controlled substances, including
- permitting a single registration for related research sites in certain circumstances,
- waiving the requirement for a new inspection in certain situations, and
- allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
Finally, the bill expresses the sense that Congress agrees with the interpretation of Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.
Cosponsors (20)
- Robert Latta (R-OH)
- Cathy Rodgers (R-WA)
- Brett Guthrie (R-KY)
- Gus Bilirakis (R-FL)
- Larry Bucshon (R-IN)
- Richard Hudson (R-NC)
- Michael Burgess (R-TX)
- Earl Carter (R-GA)
- Jeff Duncan (R-SC)
- Neal Dunn (R-FL)
- Dan Crenshaw (R-TX)
- John Joyce (R-PA)
- Troy Balderson (R-OH)
- Diana Harshbarger (R-TN)
- Mariannette Miller-Meeks (R-IA)
- Kat Cammack (R-FL)
- Rick Allen (R-GA)
- Tim Walberg (R-MI)
- John Curtis (R-UT)
- Gary Palmer (R-AL)
Subjects
- Administrative law and regulatory procedures
- Department of Justice
- Drug trafficking and controlled substances
- Licensing and registrations
- Research administration and funding
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.